News Scan
Anxiety As a Predictor of Treatment Outcome in Children and Adolescents with Depression
Anxiety disorders alone did not predict response or remission, but the total number of co-morbid illnesses was associated with remission in depressed children and adolescents treated with fluoxetine.
http://www.liebertonline.com/doi/abs/10.1089/cap.2010.0006
Low Serum HDL-Cholesterol Levels Are Associated With Long Symptom Duration In Patients With Major Depressive Disorder
These findings suggest that a low serum HDL-C level, a risk factor for coronary heart disease, is specifically associated with long-term depressive symptomatology.
http://www3.interscience.wiley.com/journal/123337734/abstract
The Efficacy of Omega-3 Supplementation for Major Depression: A Randomized Controlled Trial
In this heterogeneous sample of patients with major depressive episode, there was only a trend toward superiority of omega-3 supplementation over placebo in reducing depressive symptoms. However, there was a clear benefit of omega-3 supplementation among patients with major depressive episode without comorbid anxiety
http://article.psychiatrist.com/dao_1-login.asp?ID=10006935&RSID=70602616986345
Depression Nearly Doubles Risk of Developing Dementia Later in Life
A new study shows that having depression nearly doubles a person's risk of developing dementia later in life. The research will be published in the July 6 print issue of the journal Neurology.
Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 Outcomes
Continued treatment for depression among treatment-resistant adolescents results in remission in approximately one-third of patients, similar to adults. Eventual remission is evident within the first 6 weeks in many, suggesting that earlier intervention among nonresponders could be important.
http://ajp.psychiatryonline.org/cgi/content/abstract/167/7/782
